Conférences  >  Médecine & Soins de Santé  >  Formation médicale continue (FMC)  >  Belgique

Bioevents Ltd

We would like to invite you to attend The 3rd International Conference on Controversies in Neuropathic Pain, taking place 20-21 November 2023 in Brussels, Belgium. Following the success of the virtual conference last year, we are delighted to announce that we will once again be convening in person to engage in stimulating discussions on the most pressing and controversial issues surrounding neuropathic pain. This conference is intended to gather clinicians, translational and basic scientists who have an interest in neuropathic pain, with the aim of discussing important areas within the field. These areas will range from the clinical aspects of diagnosis, classification, and neurophysiology, to the molecular mechanisms and genetics involved in neuropathic pain. The conference will offer a platform for established researchers and junior investigators to network, collaborate and develop new research partnerships. Junior researchers will have the opportunity to present their work and receive feedback from leading experts in the field.

Tél.: [00442030514032];     Email.: ilana@bioevents-congress.com

Preclinical research, pain, neuropathic, genetics, pain classification (ICD-11), Assesment, Diagnosis, Measurement of Pain, Peripheral Neuropathic pain, Central neuropathic pain, Neuroimaging, Psychology, Pharmacology, Clincial Trials, Controversies, neuroimaging

Médecine (en général), médecine interne,    Médecine traditionnelle et médecine non conventionnelle

Bioevents Ltd

It is with great pleasure that we invite you to join us in person at The 4th European Congress on Controversies in Leukemia (Euroleuk2023) which will take place 20-21 November 2023 in Brussels, Belgium. The diagnosis and treatment of acute and chronic leukemia are changing dramatically. In recent years, numerous new drugs have entered the market, changing the prognosis of leukemia patients. In this context, a continuous exchange among peers, together with the opportunity to hear the most important news from the voices of Europe’s leading key opinion leaders, is essential to ensure the best level of care for leukemia patients. The all-new format will feature debate-style presentations on hot topics in acute and chronic leukemia, with speakers presenting contrasting views to stimulate interactive discussion with faculty and attendees. Euroleuk2023 will continue to provide clinicians and biologists with the latest recommendations for patient care, as well as insights into controversies and new therapeutic perspectives in the field.

Tél.: [00442030514032];     Email.: ilana@bioevents-congress.com

acute myeloid leukemia, AML, acute lymphoblastic leukemia, ALL, chronic lymphocytic leukemia (CLL), stem cell transplantation, leukemia, leukaemia, treatment, immunotherapy, clincial, biology, diagnosis, ELN2022, WHO2022,

Cancérologie,    Cellules souches

Bioevents Ltd

It is our pleasure to invite you to participate in the upcoming 5th European Congress on Clinical Trials in Pain (SOPATE2023) which will take place 7-8 December 2023 in Brussels, Belgium.

Chronic pain is a complex biopsychosocial phenomenon with a variety of heterogeneous clinical manifestations, pain phenotypes and co-morbidities. The management of chronic pain is still a challenge and we desperately need novel therapeutic approaches. In recent years many clinical trials addressing chronic pain failed to meet the trial endpoint despite encouraging data from preclinical research. One reason for this is that clinical trials have deficits in defining the correct inclusion/exclusion criteria, the correct endpoints and measures for clinically meaningful improvement. Furthermore, the concept that a specific treatment is only beneficial for a subgroup of patients and not for the entire group comes more and more into the focus of clinical trial design.

This Congress will bring together researchers, clinicians, industry professionals and other related experts to look at ways of improving the situation by developing better ideas and practices in clinical trials on pain and address medical devices and other interventions in the treatment and management of chronic pain.

The SOPATE2023 program will include a wealth of knowledge from our world renowned panel of experts.

Ilana Berkowitz;     Tél.: [0044-203-051-4032 ext 525];     Email.: ilana@bioevents-congress.com

acute pain, chronic pain, back pain, neropathic pain, pain in osteoarthritis, pain in rheumatoid arthritis, headache, migraine, fibromyalgio, phase 2 studies, phase 3 studies, phase 4 studies, prediction of treatment response, patient reported outcomes, alternate trial design approaches, alternative outcome measures

Anesthésie,    Médecine translationnelle, essais cliniques